Common Stock, Shares Authorized of Can-Fite BioPharma Ltd. from 31 Dec 2018 to 30 Jun 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Can-Fite BioPharma Ltd. quarterly Common Stock, Shares Authorized in shares history and change rate from 31 Dec 2018 to 30 Jun 2025.
  • Can-Fite BioPharma Ltd. Common Stock, Shares Authorized for the quarter ending 30 Jun 2025 was 20,000,000,000, a 300% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 20,000,000,000 +15,000,000,000 +300% 30 Jun 2025 6-K 28 Aug 2025 2025 Q2
Q4 2024 10,000,000,000 +5,000,000,000 +100% 31 Dec 2024 6-K 28 Aug 2025 2025 Q2
Q2 2024 5,000,000,000 0 0% 30 Jun 2024 6-K 29 Aug 2024 2024 Q2
Q4 2023 5,000,000,000 0 0% 31 Dec 2023 20-F 14 Apr 2025 2024 FY
Q2 2023 5,000,000,000 0 0% 30 Jun 2023 6-K 31 Aug 2023 2023 Q2
Q4 2022 5,000,000,000 0 0% 31 Dec 2022 20-F 28 Mar 2024 2023 FY
Q2 2022 5,000,000,000 0 0% 30 Jun 2022 6-K 25 Aug 2022 2022 Q2
Q4 2021 5,000,000,000 +4,000,000,000 +400% 31 Dec 2021 20-F 30 Mar 2023 2022 FY
Q2 2021 5,000,000,000 +4,500,000,000 +900% 30 Jun 2021 6-K 26 Aug 2021 2021 Q2
Q4 2020 1,000,000,000 +500,000,000 +100% 31 Dec 2020 20-F 24 Mar 2022 2021 FY
Q2 2020 500,000,000 30 Jun 2020 6-K 27 Aug 2020 2020 Q2
Q4 2019 500,000,000 0 0% 31 Dec 2019 20-F 25 Mar 2021 2020 FY
Q4 2018 500,000,000 31 Dec 2018 6-K 01 Jun 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.